This story originally appeared on Stockhead.
Zelira Therapeutics (ASX:ZLD) will launch the world’s first clinically validated medicinal cannabis product for insomnia later this year after a positive clinical trial result.
The company’s ZLT-101 formulation was tested in 23 patients with c...
↬ Click here to view the full article/gallery on D'Marge
The post World’s First Clinically Validated Cannabis Product For Insomnia Set To Launch appeared first on DMARGE.
from DMARGE https://ift.tt/2V61mxo
No comments:
Post a Comment